As Rab3B and DDX6 play a similar role in driving NSCLC progression, we tested whether DDX6 acts as a partner of Rab3B to mediate Rab3B-induced aggressive phenotype in NSCLC cells. Here, DDX6 is linked to non-small cell lung carcinoma.